These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29129888)

  • 21. Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen.
    Ueda S; Ito J; Harada N; Harada S; Sasano H; Sandhu Y; Tanabe Y; Abe S; Shiota S; Kodama Y; Nagaoka T; Makino F; Chiba A; Akiba H; Atsuta R; Miyake S; Takahashi K
    Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of short-term oral immunotherapy with Cry j1-galactomannan conjugate on quality of life in Japanese cedar pollinosis patients: A prospective, randomized, open-label study.
    Murakami D; Sawatsubashi M; Kikkawa S; Ejima M; Saito A; Kato A; Komune S
    Auris Nasus Larynx; 2016 Feb; 43(1):50-5. PubMed ID: 26197940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A MULTICENTER CLINICAL SURVEY ABOUT THE PREVALENCE OF JAPANESE CYPRESS POLLINOSIS AND THE EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH JAPANESE CEDAR POLLEN EXTRACT DURING JAPANESE CYPRESS POLLEN DISPERSAL PERIOD].
    Oka A; Yuta A; Okawa Y; Masuno S; Tsunoda T; Takahara E; Terada A; Kanai K; Nagakura H; Mimura H; Arao H; Ueyama S; Ueyama A; Tokuda R; Bamba H; Nakazato H; Nakazato M; Amesara R; Nakai S; Araki S; Sakaida M; Tokuriki M; Hama T; Chiba M; Ikeda H; Togawa A; Tsuzuki H; Hyo Y; Niitsu S; Ohkawa C; Nakamoto S; Takeo T; Kumanomidou H; Kanai K; Kitamura H; Sugiura R; Okano M
    Arerugi; 2023; 72(9):1138-1146. PubMed ID: 37967960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [ANALYSIS OF BACKGROUNDS AND LEVEL OF UNDERSTANDING OF TREATMENT OF POOR ADHERENCE AND DROPOUT CASES ON SUBLINGUAL IMMUNOTHERAPY FOR JAPANESE CEDAR POLLINOSIS IN THE FIRST FOLLOW-UP YEAR].
    Kikkawa S; Kamijo A; Nakagome K; Soma T; Kobayashi T; Uchida Y; Morita E; Nagata M; Inoue T; Kase Y
    Arerugi; 2017; 66(9):1165-1171. PubMed ID: 29129887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Relationship of Pollen Dispersal with Allergy Symptoms and Immunotherapy: Allergen Immunotherapy Improves Symptoms in the Late Period of Japanese Cedar Pollen Dispersal.
    Sakurai T; Yonekura S; Iinuma T; Sakurai D; Morimoto Y; Kaneko S; Okamoto Y
    Int Arch Allergy Immunol; 2018; 177(3):245-254. PubMed ID: 30021201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized double-blind comparative study of sublingual immunotherapy for cedar pollinosis.
    Okubo K; Gotoh M; Fujieda S; Okano M; Yoshida H; Morikawa H; Masuyama K; Okamoto Y; Kobayashi M
    Allergol Int; 2008 Sep; 57(3):265-75. PubMed ID: 18566549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sublingual immunotherapy for Japanese cedar pollinosis.
    Okubo K; Gotoh M
    Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T
    Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy.
    Otsuka K; Otsuka H; Matsune S; Okubo K
    Immun Inflamm Dis; 2020 Sep; 8(3):333-341. PubMed ID: 32468704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
    Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
    Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease-Modifying Effect of Japanese Cedar Pollen Sublingual Immunotherapy Tablets.
    Yonekura S; Gotoh M; Kaneko S; Maekawa Y; Okubo K; Okamoto Y
    J Allergy Clin Immunol Pract; 2021 Nov; 9(11):4103-4116.e14. PubMed ID: 34333190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis.
    Kikuoka H; Kouzaki H; Matsumoto K; Arai H; Yamamoto S; Tojima I; Shimizu S; Miyashita H; Ogawa Y; Osada T; Okano M; Yuta A; Shimizu T
    Clin Immunol; 2020 Jan; 210():108310. PubMed ID: 31743749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Combined Effects of Sublingual Immunotherapy and Lactobacillus acidophilus-Producing Extract on Cedar Pollinosis Symptoms.
    Hirobumi I; Sasuga Y
    Cureus; 2023 Jul; 15(7):e41374. PubMed ID: 37408939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen.
    Yamanaka K; Shah SA; Sakaida H; Yamagiwa A; Masuda S; Mizutani H; Takeuchi K
    Allergol Int; 2015 Jan; 64(1):54-9. PubMed ID: 25605528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary Clinical Trial of Biomarkers to Predict Response to Sublingual Immunotherapy for Japanese Cedar Pollinosis.
    Takahara E; Matsune S; Ishida M; Wakayama N; Okubo K
    J Nippon Med Sch; 2020 Dec; 87(5):277-284. PubMed ID: 32074537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultra short pre-seasonal subcutaneous immunotherapy and pre-coseasonal sublingual immunotherapy for pollen allergy: an evaluation of patient's preference in real life.
    Manzotti G; Pappacoda A; Dimatteo M; Scolari C; Riario-Sforza GG; Incorvaia C
    Eur Ann Allergy Clin Immunol; 2013 Aug; 45(4):138-43. PubMed ID: 24067339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [EFFICACY AND SAFETY OF PEDIATRIC SUBLINGUAL IMMMUNOTHERAPY WITH CEDARCURE
    Yuta A; Ogawa Y; Suzuki Y; Ogihara H; Kozaki H; Shimizu T
    Arerugi; 2020; 69(9):909-917. PubMed ID: 33191379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The enhanced clinical efficacy by treated years and the sustained efficacy after treatment of sublingual immunotherapy for Japanese cedar pollinosis].
    Yuta A; Ogihara H; Miyamoto Y; Takeuchi K; Okubo K
    Arerugi; 2010 Nov; 59(11):1552-61. PubMed ID: 21119301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adverse Events of Sublingual Immunotherapy in 207 Patients with Japanese Cedar Pollinosis].
    Ogawa Y; Yuta A; Arikata M; Kozaki H; Ohta N; Suzuki Y; Shimizu T
    Nihon Jibiinkoka Gakkai Kaiho; 2015 Dec; 118(12):1429-35. PubMed ID: 26964395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Japanese cedar-specific sublingual immunotherapy on allergen-specific TH2 cell counts in blood.
    Nomura T; Suzuki M; Yokota M; Nakamura Y; Ozeki K; Ito Y; Tsuge I; Saitoh S
    Ann Allergy Asthma Immunol; 2016 Jul; 117(1):72-78.e4. PubMed ID: 27156747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.